A086450 Stock Overview
DongKook Pharmaceutical Co., Ltd. manufactures, sells, and imports of pharmaceuticals, quasi-drugs, and injections in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
DongKook Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩15,730.00 |
| 52 Week High | ₩19,620.00 |
| 52 Week Low | ₩13,000.00 |
| Beta | 0.66 |
| 1 Month Change | -1.87% |
| 3 Month Change | -10.06% |
| 1 Year Change | 2.88% |
| 3 Year Change | -45.85% |
| 5 Year Change | 36.31% |
| Change since IPO | 217.53% |
Recent News & Updates
Recent updates
We Think DongKook Pharmaceutical (KOSDAQ:086450) Can Stay On Top Of Its Debt
May 06
DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 06How Much Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Do Insiders Own?
Mar 15The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Has Gained 136%, So Why Not Pay It Some Attention?
Feb 28DongKook Pharmaceutical Co., Ltd.'s (KOSDAQ:086450) Stock Is Going Strong: Is the Market Following Fundamentals?
Feb 14
DongKook Pharmaceutical (KOSDAQ:086450) Seems To Use Debt Quite Sensibly
Feb 01DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 19The Attractive Combination That Could Earn DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) A Place In Your Dividend Portfolio
Jan 06DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Dec 24With EPS Growth And More, DongKook Pharmaceutical (KOSDAQ:086450) Is Interesting
Dec 21What Kind Of Investors Own Most Of DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)?
Dec 08The DongKook Pharmaceutical (KOSDAQ:086450) Share Price Is Up 177% And Shareholders Are Boasting About It
Nov 23Shareholder Returns
| A086450 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -3.0% | -5.0% | -4.3% |
| 1Y | 2.9% | -1.4% | -1.0% |
Return vs Industry: A086450 exceeded the KR Pharmaceuticals industry which returned -1.4% over the past year.
Return vs Market: A086450 exceeded the KR Market which returned -1% over the past year.
Price Volatility
| A086450 volatility | |
|---|---|
| A086450 Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 4.6% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A086450 has not had significant price volatility in the past 3 months.
Volatility Over Time: A086450's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 1,105 | Heung-Ju Oh | www.dkpharm.co.kr |
DongKook Pharmaceutical Co., Ltd. manufactures, sells, and imports of pharmaceuticals, quasi-drugs, and injections in South Korea and internationally. The company offers contrast media and medical devices. It also involved in real estate development business.
DongKook Pharmaceutical Co., Ltd. Fundamentals Summary
| A086450 fundamental statistics | |
|---|---|
| Market cap | ₩691.53b |
| Earnings (TTM) | ₩47.18b |
| Revenue (TTM) | ₩730.99b |
14.7x
P/E Ratio0.9x
P/S RatioIs A086450 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A086450 income statement (TTM) | |
|---|---|
| Revenue | ₩730.99b |
| Cost of Revenue | ₩320.44b |
| Gross Profit | ₩410.55b |
| Other Expenses | ₩363.38b |
| Earnings | ₩47.18b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.07k |
| Gross Margin | 56.16% |
| Net Profit Margin | 6.45% |
| Debt/Equity Ratio | 12.0% |
How did A086450 perform over the long term?
See historical performance and comparison